name

»ýüÀûÇÕ¼º
ISO 10993 »ý¹°ÇÐÀûÀûÇÕ¼º
ISO 10993 »ý¹°ÇÐÀûÀûÇÕ¼º

ISO 10993 »ýüÀûÇÕ¼º (»ý¹°ÇÐÀû ¾ÈÀü¼º) ½ÃÇè

ISO 10993Àº ÀÇ·á±â±âÀÇ »ý¹°ÇÐÀû ¾ÈÀü¼ºÀ» Æò°¡Çϱâ À§ÇÑ ±¹Á¦ Ç¥ÁØÀ¸·Î, ȯÀÚÀÇ ¾ÈÀü°ú Á¦Ç°ÀÇ ½Å·Ú¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ACTS´Â ISO 10993¿¡ ±â¹ÝÇÑ ´Ù¾çÇÑ »ýüÀûÇÕ¼º ½ÃÇèÀ» ¼öÇàÇÏ¿© °í°´ÀÇ ÀÇ·á±â±â°¡ ±Û·Î¹ú ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·Çϵµ·Ï Áö¿øÇÕ´Ï´Ù.

¼­ºñ½º ǰ¸ñ

½ÃÇè Ç׸ñ ½ÃÇè ¼¼ºÎ ³»¿ë Àû¿ë ±Ô°Ý
¼¼Æ÷µ¶¼º ½ÃÇè
(Cytotoxicity Test)
MEM Elution, Agar Overlay Direct Contact, MTT & XTT Assay, Neutral Red Uptake, Colony Formulation ISO 10993-5
°¨ÀÛ¼º ½ÃÇè
(Skin Sensitization Test)
GPMT ISO 10993-10
Çdz»¹ÝÀÀ ½ÃÇè
(Intracutaneous Reactivity Test)
ÇǺΠ±¹¼Ò ¹ÝÀÀ Æò°¡ ISO 10993-23
Àڱؼº ½ÃÇè
(Irritation Test)
ÇǺΠÀÚ±Ø (Primary Skin Irritation), ±¸°­Á¡¸· ÀÚ±Ø (Mucosal Irritation), ¾ÈÀÚ±Ø (Ocular Irritation) ISO 10993-23
±Þ¼ºÀü½Åµ¶¼º ½ÃÇè
(Acute Systemic Toxicity Test)
´Ü±âÀûÀÎ Àü½Å µ¶¼º ¹ÝÀÀ Æò°¡ ISO 10993-11
¹ß¿­¼º ½ÃÇè
(Pyrogenicity Test)
¹°Áú¸Å°³ ¹ß¿­¼º (Material-Mediated Pyrogen Test) ISO 10993-11 & USP <151>
¹ÚÅ׸®¾Æ ¿£µµÅå½Å (Bacterial Endotoxins Test) ANSI / AAMI ST72:2019 & USP <85>
À¯Àüµ¶¼º ½ÃÇè
(Genotoxicity Test)
¹Ì»ý¹°º¹±Íµ¹¿¬º¯ÀÌ(Bacterial Reverse Mutation), ¿°»öü ÀÌ»ó(In vitro & In vivo Chromosome Aberration), ¼ÒÇÙ ½ÃÇè ISO 10993-3, ISO 10993-33, OECD 471 µî
ÀÌ½Ä ½ÃÇè
(Implantation Test)
ÇÇÇÏ/±ÙÀ° ÀÌ½Ä (Subcutaneous/Intramuscular), »À ÀÌ½Ä (Bone Implantation), °ü·Ã ÀÓ»ó ºÎÀ§ ÀÌ½Ä ISO 10993-6
Ç÷¾×ÀûÇÕ¼º ½ÃÇè
(Hemocompatibility Test)
¿ëÇ÷¼º(ASTM Hemolysis), ÇÁ·ÎÆ®·Òºó ½Ã°£(Prothrombin Time), Ç÷¼ÒÆÇ ÀÀÁý(Platelet Aggregation), Ç÷ÀüÁõ Æò°¡ ISO 10993-4 & ASTM F756

OECD GLP ÀüÀÓ»ó µ¿¹°½ÃÇè

Á¦Ç°±º ½ÃÇè Ç׸ñ
Èí¼ö¼º Àç·á ÀÌ½ÄµÈ ÀÇ·á±â±âÀÇ ±¹¼Ò È¿°ú¿Í ºÐÇØ ¿©ºÎ Æò°¡
Èí¼ö¼º ºÀÇÕ»ç (Absorbable suture) ºÀÇÕ»çÀÇ ÀÎÀå·Â À¯Áö, °¡½Ã À¯Áö °­µµ Æò°¡
Á¶Á÷¼öº¹¿ë»ýüÀç·á (Dermal fillers) ÀÌ½Ä ÈÄ ÀÜÁ¸·® ÃøÁ¤ ¹× ±¹¼Ò È¿°ú Æò°¡
Èí¼ö¼ºÄ¡ÁÖÁ¶Á÷Àç»ýÀ¯µµÀç
(Collagen membrane)
Èí¼ö¼ºÄ¡ÁÖÁ¶Á÷Àç»ýÀ¯µµÀçÀÇ ÀÌ½Ä ÈÄ GBR/GTR ÃøÁ¤ ¹× ±¹¼ÒÈ¿°ú Æò°¡
Ä¡°ú¿ë °ñÀ̽ÄÀç·á (Bone graft material) °ñÀç»ý/Èí¼öÀ² ÃøÁ¤ ¹× ±¹¼ÒÈ¿°ú Æò°¡

±âŸ ½ÃÇè °¡´ÉÇÑ ±â±â ¿¹½Ã ¸ñ·Ï

ºÐ·ù ¿¹½Ã
½ÉÀå ¹× ½ÉÇ÷°ü ±â±â Àΰø ½É¹Úµ¿±â, ºñħ½ÀÀÚµ¿Ç÷¾Ð°è, Á¤¸Æ ½ºÅÙÆ®, ¾à¹° ¹æÃâ ½ºÅÙÆ® µî
ÁöÇ÷ ¹× »óó °ü¸® ±â±â ŰÅä»ê ÁöÇ÷ µå·¹½Ì, ºñÈí¼ö¼º ü³»µµÆ÷Çü ÁöÇ÷¿ëǰ µî
À§Àå°ü Àåºñ ºñÈí¼ö¼º ÀÌ½Ä¿ë ¸Å½¬, ½ÄµµÀ§ ³»½Ã°æ °Ë»ç Àåºñ µî
±âŸ ±â±â °£Åõ¼® Àåºñ, ¾È±¸ ¹× ½Å°æ °ü·Ã ±â±â µî

°ü·ÃµÈ »ó´ãÀ» ¿øÇÏ½Ã¸é ¾ðÁ¦µçÁö ACTS¿¡ ¹®ÀÇÇØ ÁÖ¼¼¿ä.

ÄÁ¼³ÆÃ ´ã´ç
¿ÀÇý¿µ ¼ö¼® hy.oh@actslab.co.kr